• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肝硬化肝脏中的肝细胞癌合并胆管细胞癌

Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver.

作者信息

Shiraishi M, Takushi Y, Simoji H, Oshiro T, Shinzato S, Tanigawa N, Kusano T, Muto Y

机构信息

First Department of Surgery, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.

出版信息

J Gastroenterol. 1998 Aug;33(4):593-6. doi: 10.1007/s005350050140.

DOI:10.1007/s005350050140
PMID:9719250
Abstract

Combined hepatocellular (HCC) and cholangiocellular carcinoma (CCC) (mixed carcinoma) is a rare subtype of primary hepatic carcinoma. We report a case of mixed carcinoma that developed in a non-cirrhotic liver, in a patient who was serologically negative for both hepatitis B and C viruses. A 65-year-old Japanese woman with a 25-year history of chronic rheumatoid arthritis had been treated with steroids and anti-inflammatory drugs, and was diagnosed by ultrasonography with an asymptomatic solitary tumor in the right lobe of the liver. On computed tomography scan and hepatic arteriography, the tumor was well enhanced by contrast medium in the early phase. Based on the findings of elevated serum alpha-feto protein (AFP, 245 ng/ml) and normal carcino-embryonic antigen (CEA, 2.6 ng/ml) levels, a preoperative diagnosis of hepatocellular carcinoma was made. Right lobectomy of the liver was performed on January 7, 1997. Histological examination showed that the resected tumor consisted of combined CCC cells and HCC cells in an intermingled form, with CCC being far more dominant than HCC. The tumor was therefore determined to be a combined carcinoma, subclassified as intermingled type. This case appears to indicate that mixed type carcinoma developed in a non-cirrhotic liver, with CCC being dominant; such a finding is extremely unusual, based on previously published reports.

摘要

肝细胞癌(HCC)和胆管细胞癌(CCC)合并存在(混合性癌)是原发性肝癌中一种罕见的亚型。我们报告一例在非肝硬化肝脏中发生的混合性癌病例,该患者乙肝和丙肝病毒血清学检测均为阴性。一名65岁的日本女性,有25年慢性类风湿关节炎病史,一直在接受类固醇和抗炎药物治疗,经超声检查诊断为肝脏右叶有一个无症状的孤立性肿瘤。在计算机断层扫描和肝动脉造影检查中,肿瘤在早期造影剂增强明显。根据血清甲胎蛋白(AFP,245 ng/ml)升高和癌胚抗原(CEA,2.6 ng/ml)水平正常的检查结果,术前诊断为肝细胞癌。1997年1月7日进行了肝脏右叶切除术。组织学检查显示,切除的肿瘤由CCC细胞和HCC细胞混合组成,其中CCC远比HCC占优势。因此,该肿瘤被确定为混合性癌,归类为混合型。根据以往发表的报告,该病例似乎表明混合型癌在非肝硬化肝脏中发生,且CCC占主导;这样的发现极为罕见。

相似文献

1
Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver.非肝硬化肝脏中的肝细胞癌合并胆管细胞癌
J Gastroenterol. 1998 Aug;33(4):593-6. doi: 10.1007/s005350050140.
2
Heterochronous development of intrahepatic cholangiocellular carcinoma following hepatocellular carcinoma in a hepatitis B virus carrier.
Intern Med. 2001 Jul;40(7):624-30. doi: 10.2169/internalmedicine.40.624.
3
Hepatocellular carcinoma in a non-cirrhotic liver. Two case reports and literature review.非肝硬化肝脏中的肝细胞癌:两例病例报告及文献综述
Panminerva Med. 2000 Jun;42(2):151-4.
4
Four immunohistochemically different primary liver cancers in one patient.一名患者体内存在四种免疫组化结果不同的原发性肝癌。
J Gastroenterol. 2002;37(9):750-4. doi: 10.1007/s005350200123.
5
Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia.具有局灶性结节性增生影像学特征的肝内胆管混合性肝癌。
World J Gastroenterol. 2009 Aug 21;15(31):3940-3. doi: 10.3748/wjg.15.3940.
6
Occurrence of hepatocellular and cholangiocellular carcinoma in different hepatic lobes.肝细胞癌和胆管细胞癌在不同肝叶中的发生情况。
Hepatogastroenterology. 2003 Jan-Feb;50(49):65-8.
7
Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver:a case report.包含肝细胞癌和胆管细胞癌的肝内胆管细胞癌,一种极其罕见的肝脏肿瘤:病例报告
J Med Invest. 2008 Feb;55(1-2):161-5. doi: 10.2152/jmi.55.161.
8
Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.肝细胞癌与胆管癌混合型(双表型)肿瘤:临床特征、超声造影及计算机断层扫描的影像学特征
BMC Cancer. 2016 Feb 25;16:158. doi: 10.1186/s12885-016-2156-x.
9
Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.肝细胞癌和胆管癌混合型的手术治疗病例。
Hepatogastroenterology. 2002 Jul-Aug;49(46):1083-6.
10
An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma.13例肝细胞癌合并胆管细胞癌的免疫组织化学分析。
Liver. 1995 Feb;15(1):9-15. doi: 10.1111/j.1600-0676.1995.tb00099.x.

引用本文的文献

1
Postresection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma according to the 2010 World Health Organization classification: single-center experience of 168 patients.根据2010年世界卫生组织分类标准的肝细胞癌-胆管癌联合切除术后预后:168例患者的单中心经验
Ann Surg Treat Res. 2021 May;100(5):260-269. doi: 10.4174/astr.2021.100.5.260. Epub 2021 Apr 29.
2
Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection.肝内胆管细胞癌和肝细胞癌-胆管细胞癌联合切除术后患者的预后。
Cancer Med. 2019 Oct;8(13):5862-5871. doi: 10.1002/cam4.2495. Epub 2019 Aug 13.
3
Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification.
根据2010年世界卫生组织分类标准的肝细胞癌-胆管癌联合切除术后预后
World J Surg. 2017 May;41(5):1347-1357. doi: 10.1007/s00268-016-3837-y.
4
Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.肝细胞癌-胆管癌、肝细胞癌及肝内胆管癌联合切除术后的结果
J Gastrointest Surg. 2016 Feb;20(2):411-20. doi: 10.1007/s11605-015-3045-3. Epub 2015 Dec 1.